Clinical recommendations establish updated genetic risk stratification in adults with acute myeloid leukemia receiving less-intensive therapies, highlighting tailored prognostic assessment.
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.
No takes yet. Share an insight, caveat, or question.
Döhner et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: